RDHL Insider Trading Activity and SEC Form 4 Filings
RDHL insider trading summary
Over the past 12 months, insiders at RedHill Biopharma Ltd. (RDHL) reported 2 sales worth $3K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $3K.
Latest RDHL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Gilead Raday | Chief Operating Officer | Sell | $1K (14,310,000 @ $0.00) |
| Apr 6, 2026 | Gilead Raday | Chief Operating Officer | Sell | $2K (15,740,000 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.